Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search
Simple search

Simple search

*
(*) mandatory field




 

Other search option(s)

227 matching term(s)

Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • GERMANY
    • Berlin
    • BERLIN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Charité - Universitätsmedizin Berlin (CVK)
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • DORTMUND
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes)
    • Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
    • More information
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CHEK2 and PTEN genes)
    • Institut für Humangenetik der Universität Göttingen
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • UKE - Universitätsklinikum Hamburg-Eppendorf
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
    • More information
    • GERMANY
    • Bayern
    • BAD STEBEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (CHEK2, BRCA1, BRCA2, PALB2, RAD51C, RAD51D genes)
    • Institut für angewandte Humangenetik und Onkogenetik
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes: sequencing, MLPA)
    • Pränatalmedizin München
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • Medizinisches Versorgungszentrum Humane Genetik
    • More information
    • GERMANY
    • Bayern
    • NEU-ULM
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Paxis und Labor Dr. med Karl Mehnert
    • More information
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes)
    • Universitätsklinikum Ulm
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Accreditation
    • Molecular diagnosis of Breast cancer. BRCA1, BRCA2 genes
    • Laboratorio de Análisis Dr. Echevarne
    • More information
    • GERMANY
    • Bayern
    • MÜNCHEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRCA3, BRIP1, CHEK2, RAD51D genes)
    • Medizinisch Genetisches Zentrum München
    • More information
    • GERMANY
    • Schleswig-Holstein
    • LÜBECK
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Universitätsklinikum Schleswig-Holstein - Campus Lübeck
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, MRE11A, PALB2, RAD51C)
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • More information
    • UNITED KINGDOM
    • Greater Manchester
    • MANCHESTER
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • St Mary's Hospital
    • More information
    • BELGIUM
    • VLAAMS BRABANT
    • LEUVEN
    • Accreditation
    • Molecular diagnosis of Predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2 (1100delC))
    • University Hospitals Leuven - Gasthuisberg
    • More information
    • BELGIUM
    • OOST-VLAANDEREN
    • GENT
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1, BRCA2 genes)
    • Ghent University Hospital - UZGent
    • More information
    • BELGIUM
    • OOST-VLAANDEREN
    • GENT
    • Accreditation
    • Molecular diagnosis of predisposition to breast cancer (CHEK2)
    • Ghent University Hospital - UZGent
    • More information
    • BELGIUM
    • ANTWERPEN
    • ANTWERPEN-EDEGEM
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 & BRCA2 genes)
    • University and University Hospital of Antwerp - UZA
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUSSELS
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • Erasme Hospital - ULB
    • More information
    • UNITED KINGDOM
    • Merseyside
    • LIVERPOOL
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
    • Liverpool Women's NHS Foundation Trust
    • More information
    • GERMANY
    • Bayern
    • WÜRZBURG
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53 genes: NGS Screening Panel)
    • Universität Würzburg - Biozentrum
    • More information
    • UNITED KINGDOM
    • Lanarkshire
    • GLASGOW
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA2 gene)
    • Southern General Hospital
    • More information
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
    • Birmingham Women's NHS Foundation Trust
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Gemeinschaftspraxis Dr. Prager / Dr. Junge / Dr. Hennig / Dr. Linné
    • More information
    • UNITED KINGDOM
    • Nottinghamshire
    • NOTTINGHAM
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • Nottingham City Hospital
    • More information
    • UNITED KINGDOM
    • South Glamorgan
    • CARDIFF
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes: Molecular diagnosis through sequencing and dosage analysis)
    • University Hospital of Wales
    • More information
    • UNITED KINGDOM
    • Wiltshire
    • SALISBURY
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes: Mut. screening by CSCE, SNPlex and sequencing; dosage by MLPA)
    • Salisbury District Hospital
    • More information
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Medizinische Hochschule Hannover
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular Diagnosis of Breast/Ovarian Cancer ( BRCA1 & BRCA2 genes)
    • Great Ormond Street Hospital for Children, York House
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing / MLPA, RAD51C gene: sequencing)
    • GenteQ GmbH
    • More information
    • GERMANY
    • Baden-Württemberg
    • MANNHEIM
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, RAD51C, RAD51D genes)
    • Zentrum für Humangenetik Mannheim
    • More information
    • BELGIUM
    • HAINAUT
    • GOSSELIES
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • Institut de Pathologie et de Génétique - Gosselies
    • More information
    • IRELAND
    • County Dublin
    • DUBLIN
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • National Centre for Medical Genetics
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Universitätsklinikum Regensburg
    • More information
    • UNITED KINGDOM
    • Grampian
    • ABERDEEN
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 -screen and known mutation- and BRCA2 - MLPA only - genes)
    • Aberdeen Royal Infirmary, Polwarth Building
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • St George's University of London
    • More information
    • SWITZERLAND
    • Suisse Romande
    • GENÈVE
    • Accreditation
    • Diagnostic en biologie moléculaire des prédispositions au cancer du sein et de l'ovaire: analyse des gènes BRCA1 et BRCA2
    • Centre Médical Universitaire - CMU
    • More information
    • NETHERLANDS
    • Noord-Holland
    • AMSTERDAM
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • VUmc - VU medisch centrum
    • More information
    • NETHERLANDS
    • Zuid-Holland
    • ROTTERDAM
    • Accreditation
    • Molecular diagnosis of Predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • Erasmus MC, Faculteitsgebouw
    • More information
    • NETHERLANDS
    • Limburg
    • MAASTRICHT
    • Accreditation
    • Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • AZM - Academisch Ziekenhuis Maastricht
    • More information
    • NETHERLANDS
    • Zuid-Holland
    • LEIDEN
    • Accreditation
    • Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • LUMC - Leids Universitair Medisch Centrum
    • More information
    • NETHERLANDS
    • Gelderland
    • NIJMEGEN
    • Accreditation
    • Molecular diagnosis of Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • Radboudumc - Radboud universitair medisch centrum
    • More information
    • NETHERLANDS
    • Groningen
    • GRONINGEN
    • Accreditation
    • Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2 gene)
    • UMCG - Universitair Medisch Centrum Groningen
    • More information
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes by DNA sequencing and dosage)
    • Addenbrooke's Hospital
    • More information
    • NETHERLANDS
    • Utrecht
    • UTRECHT
    • Accreditation
    • Molecular diagnosis of Hereditary Breast and Ovarian Cancer (BRCA1, BRCA2 and BRIP1 gene)
    • UMC Utrecht - Universitair Medisch Centrum Utrecht
    • More information
    • GERMANY
    • Baden-Württemberg
    • FREIBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BARD1, BRCA1, BRCA2, RAD51C genes)
    • Praxis für Humangenetik Freiburg
    • More information
    • UNITED KINGDOM
    • Tyne & Wear
    • NEWCASTLE UPON TYNE
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1, BRCA2 genes: Testing for known mutations in family members)
    • International Centre for Life
    • More information
    • UNITED KINGDOM
    • Oxfordshire
    • OXFORD
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
    • The Churchill Hospital
    • More information
    • ESTONIA
    • Tartu
    • TARTU
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer (APEX: BRCA1, BRCA2, CHEK2, RAD51 and NBN genes ; total sequencing: BRCA1 and BRCA2 genes)
    • Asper Biotech Ltd.
    • More information
    • GERMANY
    • Bayern
    • MARTINSRIED
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Centogene AG
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BARD1, BRCA1, BRCA2, BRIP1, CHD1, CHEK2, MRE11A, MSH6, NBN, PALB2, PTEN, RAD50, RAD51C, STK11, TP53 genes: NGS Screening Panel)
    • Centogene AG
    • More information
    • GERMANY
    • Baden-Württemberg
    • HEIDELBERG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Institut für Humangenetik am Universitätsklinikum Heidelberg
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHK2 genes)
    • MVZ Labor Dr. Reising-Ackermann und Kollegen
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Zentrum für Humangenetik
    • More information
    • SWEDEN
    • Västra Götalandsregionen
    • GÖTEBORG
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Sahlgrenska university hospital
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • MVZ Fenner & Krasemann
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • AARGAU
    • Accreditation
    • Molecular diagnosis of RAD51C related diseases (RAD51C gene: sequencing and deletion analysis)
    • Kantonsspital Aargau
    • More information
    • SWITZERLAND
    • Suisse Alémanique
    • AARGAU
    • Accreditation
    • Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1/BRCA2 genes sequencing and deletion analysis)
    • Kantonsspital Aargau
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Preimplantation molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2: by linkage and mutation analysis)
    • Institute for Women's Health
    • More information
    • SLOVAKIA
    • Bratislavsky kraj
    • BRATISLAVA
    • Accreditation
    • Molecular diagnosis of susceptibility to hereditary breast cancer (BRCA1, BRCA2 genes: exons including intron bounderies, sequencing and MLPA ; CHEK2 gene: exons 9 and 10 by MLPA)
    • Onkologicky ustav sv. Alzbety s.r.o.
    • More information
    • UNITED KINGDOM
    • West Yorkshire
    • LEEDS
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (comprehensive mutation screening of BRCA1 & BRCA2, including large rearrangements)
    • St James's University Hospital
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2 genes)
    • Guy's Hospital
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (RAD51D, PALB2, PTEN genes)
    • CeGaT GmbH
    • More information
    • CANADA
    • Ontario
    • MISSISSAUGA
    • Accreditation
    • Molecular diagnosis of Breast Cancer, familial (by Sanger sequencing- coding region BRCA1, BRCA2)
    • Trillium Health Partners- Credit Valley Site
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • IFLb Laboratoriumsmedizin Berlin GmbH
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • KÖLN
    • Accreditation
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2 genes)
    • laboratoriumsmedizin köln - Dres. med. Wisplinghoff und Kollegen
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • VILLEJUIF
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • CLCC Institut de cancérologie Gustave Roussy
    • More information
    • FRANCE
    • AUVERGNE
    • CLERMONT-FERRAND
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1, BRCA2 genes: sequencing, MLPA)
    • CLCC Jean Perrin
    • More information
    • FRANCE
    • RHONE-ALPES
    • LYON
    • Search for mutations in BRCA1 and BRCA2 genes in familial breast cancer
    • CHU de Lyon HCL - GH Edouard Herriot
    • More information
    • FRANCE
    • LORRAINE
    • VANDOEUVRE-LÈS-NANCY
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2)
    • CHU de Nancy - Hôpital de Brabois
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Search for germinal mutations and big stature rearragements of PALB2, BRCA1 and BRCA2 genes
    • CLCC Institut Paoli Calmettes
    • More information
    • FRANCE
    • PROVENCE-ALPES-COTE D'AZUR
    • MARSEILLE
    • Search for somatic modifications in breast cancer (ERBB2 gene)
    • CLCC Institut Paoli Calmettes
    • More information
    • FRANCE
    • BASSE-NORMANDIE
    • CAEN
    • Search for mutations in BRCA1 and BRCA2 genes in breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • CLCC François Baclesse
    • More information
    • FRANCE
    • AQUITAINE
    • BORDEAUX
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • CLCC Institut Bergonié
    • More information
    • FRANCE
    • PAYS DE LA LOIRE
    • NANTES
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • CHU de Nantes - Institut de Biologie
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • CLCC Institut Curie
    • More information
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • CHRU de Montpellier - Hôpital Arnaud de Villeneuve
    • More information
    • FRANCE
    • MIDI-PYRENEES
    • TOULOUSE
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 ans BRCA2 genes)
    • CLCC Institut Claudius Regaud - IUCT Oncopole
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • CHU de Reims - Hôpital Maison Blanche
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • More information
    • FRANCE
    • CHAMPAGNE-ARDENNE
    • REIMS
    • Molecular diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • CLCC Institut Jean Godinot
    • More information
    • FRANCE
    • ALSACE
    • STRASBOURG
    • ITALY
    • PIEMONTE
    • TORINO
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, PALB2 genes)
    • Azienda Ospedaliero-Universitaria San Giovanni Battista di Torino
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of familial breast cancer
    • Azienda Ospedaliera Universitaria Policlinico di Tor Vergata
    • More information
    • ITALY
    • LOMBARDIA
    • CREMONA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1, BRCA2, PALB2, TP53 genes)
    • Azienda Ospedaliera Istituti Ospitalieri di Cremona
    • More information
    • ITALY
    • CAMPANIA
    • NAPOLI
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Biotecnologie Avanzate Srl
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • Hospital de la Santa Creu i Sant Pau
    • More information
    • SPAIN
    • Cataluña
    • SABADELL
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Corporación Sanitaria Parc Taulí
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of proneness to familial breast cancer (BRCA1 and BRCA2 genes)
    • Laboratorio Genoma
    • More information
    • GERMANY
    • Baden-Württemberg
    • FREIBURG
    • Molecular diagnosis of predisposition to breast and ovarian cancer (CHEK2 (110delC and exon9-10del), BRCA1, BRCA2, PALB2, RAD51C, RAD51D genes)
    • Institut für Humangenetik am Universitätsklinikum Freiburg
    • More information
    • SPAIN
    • Aragón
    • ZARAGOZA
    • Molecular diagnosis of predisposition to breast cancer (c-myc, HER-2)
    • Centro de Análisis Genéticos
    • More information
    • SPAIN
    • Galicia
    • SANTIAGO DE COMPOSTELA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • CHUS - Complejo Hospitalario Universitario de Santiago
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
    • IRCCS Ospedale San Raffaele
    • More information
    • SPAIN
    • Cataluña
    • L'HOSPITALET DE LLOBREGAT
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes - CSCE/MLPA)
    • ICO L'Hospitalet
    • More information
    • SPAIN
    • Castilla - León
    • VALLADOLID
    • Molecular diagnosis of breast cancer (BRCA1 and BRCA2 genes)
    • IBGM - Instituto de Biología y Genética Molecular
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, CHEK2, PALB2, PTEN genes / array-CGH)
    • Policlínica Gipuzkoa
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C, RAD51D genes)
    • Institut für Medizinische Genetik und angewandte Genomik Tübingen
    • More information
    • ITALY
    • VENETO
    • PADOVA
    • Molecular diagnosis of predisposition to hereditary familial breast ovary cancer (BRCA1 and BRCA2 genes)
    • Istituto Oncologico Veneto IRCCS
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • FERRARA
    • Molecular diagnosis of familial breast cancer
    • A.O.U. di Ferrara - Polo Chimico-Bio-Medico
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • PARMA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Azienda Ospedaliera Universitaria di Parma
    • More information
    • SPAIN
    • Andalucía
    • SEVILLA
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes / deletions and duplications)
    • Hospital Universitario Virgen del Rocío
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (entire coding sequence of BRCA1 and BRCA2 genes; large deletions by MLPA kit P002 (BRCA1), kit P045 (BRCA2))
    • Hospital Universitario Donostia
    • More information
    • PORTUGAL
    • SUL
    • LISBOA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
    • More information
    • GERMANY
    • Niedersachsen
    • HANNOVER
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • MVZ wagnerstibbe für Laboratoriumsmedizin und Pathologie GmbH
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, CHEK2, PALB2, BRIP1, BARD1, RAD51C, PTEN, RAD51D genes)
    • Sistemas Genómicos S.L.
    • More information
    • DENMARK
    • Fyn
    • ODENSE
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2)
    • Odense University hospital
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Hospital Universitario La Fe - Campanar
    • More information
    • AUSTRIA
    • STEIERMARK
    • GRAZ
    • Molecular diagnosis of PTEN-associated syndromes (PTEN gene)
    • Medizinische Universität Graz
    • More information
    • AUSTRIA
    • STEIERMARK
    • GRAZ
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, and RAD51D genes)
    • Medizinische Universität Graz
    • More information
    • SPAIN
    • Aragón
    • ZARAGOZA
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes / DHPLC - sequencing - MLPA)
    • Hospital Universitario Miguel Servet
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • Praxis Dres. Gencik
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer (BRCA1, BRCA2, CHEK2 and PALB2 complete gene sequencing; screening for BRCA1 and BRCA2 rearrangements by MLPA)
    • National center for scientific research Demokritos
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PTEN, RAD51C, XRCC2 genes)
    • Klinikum Stuttgart - Standort Olgahospital
    • More information
    • PORTUGAL
    • SUL
    • LISBOA
    • Molecular diagnosis of predisposition to breast cancer (BRCA1 and BRCA2 genes)
    • Faculdade de Medicina da Universidade de Lisboa
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Instituto Português de Oncologia do Porto, EPE / IPOFG - CRO Porto
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Hospital Clínic de Barcelona
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of predisposition to breast and/or ovarian cancer (BRCA1, BRCA2 and CHEK2 genes)
    • Leto Maternity Hospital
    • More information
    • HUNGARY
    • Dél-Dunántúl
    • PECS
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Clinical Center - University of Pécs
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUXELLES
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 & BRCA2)
    • Université Catholique de Louvain - UCL
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1/BRCA2 gene: target mutation analysis - single mutation (187delAG (BRCA1), 5385insC (BRCA1), 6174delT(BRCA2), c.156_157insAlu (BRCA2), sequence analysis of the entire coding region, and deletion/dluplication analysis by MLPA)
    • CGC Genetics / Centro de Genética Clínica
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of Hereditary breast cancer syndrome (RAD51 gene: sequencing of the entire coding region)
    • CGC Genetics / Centro de Genética Clínica
    • More information
    • NETHERLANDS
    • Noord-Holland
    • AMSTERDAM
    • Molecular diagnosis of Predisposition to breast and ovarian cancer (BRCA1 and BRCA2 gene)
    • Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Preimplantation genetic diagnosis of the familial breast cancer. BRCA1 gene
    • Reprogenetics Spain S.A.
    • More information
    • SPAIN
    • Murcia
    • EL PALMAR
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Centro de Bioquímica y Genética Clínica
    • More information
    • SPAIN
    • Comunidad Valenciana
    • SANT JOAN D'ALACANT
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (PALB2 gene / sequencing; genes BRCA1, BRCA2 / sequencing, MLPA)
    • Centro Inmunológico de Alicante (CIALAB)
    • More information
    • BELGIUM
    • ARRONDISSEMENT BRUSSELS-CAPITAL
    • BRUSSELS
    • Molecular diagnosis of Predisposition to breast and ovarian cancer (BRCA1 & BRCA2 genes)
    • Universitair Ziekenhuis Brussel - UZBrussel
    • More information
    • NORWAY
    • Østlandet
    • OSLO
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2)
    • Oslo University Hospital, Ullevaal
    • More information
    • POLAND
    • Wroclaw
    • WROCLAW
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 gene)
    • Przychodnia Fundacji Uniwersytetu Medycznego we Wroclawiu
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1 and BRCA2 genes)
    • Acibadem healthcare group
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÜNSTER
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes)
    • Institut für Humangenetik des Universitätsklinikums Münster
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • MÜNSTER
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
    • Institut für Humangenetik des Universitätsklinikums Münster
    • More information
    • SWEDEN
    • Stockholms läns landsting
    • STOCKHOLM
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • Karolinska University Hospital - Solna
    • More information
    • TURKEY
    • TURKEY
    • ISTANBUL
    • Molecular diagnosis of predisposition to breast and prostate cancer (BRCA1 and BRCA2 genes)
    • Genetiks - Genetic diagnosis and research center
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • BONN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Institut für Klinische Genetik Bonn
    • More information
    • ISRAEL
    • ISRAEL
    • JERUSALEM
    • Molecular diagnosis of Breast Cancer (BRCA1, BRCA2, Mutation analysis)
    • Hadassah Ein Kerem - Hebrew University Medical Center
    • More information
    • ISRAEL
    • ISRAEL
    • RAMAT-GAN
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis, PGD)
    • Sheba Medical Center
    • More information
    • AUSTRIA
    • TIROL
    • INNSBRUCK
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Medizinische Universität Innsbruck
    • More information
    • GERMANY
    • Rheinland-Pfalz
    • MAINZ
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Universitätsmedizin Mainz
    • More information
    • POLAND
    • Poznan
    • POZNAN
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 gene: 5382insC, 4153delA, 300T/G and 3819del5 mutations)
    • NZOZ Centrum Genetyki Medycznej Genesis
    • More information
    • LITHUANIA
    • DZUKIJA
    • VILNIUS
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Vilnius University Hospital Santariskiu Klinikos
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing / MLPA)
    • Diagenom GmbH
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (RAD51C gene: sequencing)
    • Diagenom GmbH
    • More information
    • ISRAEL
    • ISRAEL
    • TEL AVIV
    • Molecular diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 full gene sequencing)
    • Pronto Diagnostics Ltd.
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of the familial breast cancer / breast and ovarian cancer. BRCA1, BRCA2 genes
    • Hospital Universitario La Paz
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • Pränatalzentrum Hamburg und Humangenetik
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Molecular diagnosis of susceptibility to familial breast cancer (BRCA1 and BRCA2 genes)
    • CLCC Oscar Lambret
    • More information
    • GERMANY
    • Baden-Württemberg
    • STUTTGART
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C, RAD51D genes)
    • Praxis für Humangenetik und Prävention
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • NZOZ GENOMED
    • More information
    • ITALY
    • LOMBARDIA
    • BRESCIA
    • Molecular diagnosis of hereditary breast cancer (BRCA1 and BRCA2 genes)
    • Biodiversity
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis for susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, PALB2 and RAD51C genes / complete sequencing; BRCA1, BRCA2 genes / MLPA)
    • IMEGEN - Instituto de Medicina Genómica
    • More information
    • ROMANIA
    • BUCURESTI
    • BUCURESTI
    • Postnatal molecular diagnosis of hereditary breast cancer (BRCA1 and BRCA2 genes: deletion/duplication analysis by MLPA)
    • National institute of legal medicine
    • More information
    • GERMANY
    • Bremen
    • BREMEN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Praxis für Humangenetik
    • More information
    • GERMANY
    • Baden-Württemberg
    • ULM
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • MVZ Humangenetik Ulm
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, RAD51C, RAD51D, PALB2, PTEN)
    • Gemeinschaftspraxis für Humangenetik
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Preimplantation genetic diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • CME Barcelona
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • AACHEN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Praxis für Humangenetik Dr. Lemmens
    • More information
    • GERMANY
    • Sachsen
    • LEIPZIG
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
    • Institut für Humangenetik am Universitätsklinikum Leipzig
    • More information
    • GERMANY
    • Hessen
    • WIESBADEN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing)
    • Institut für Humangenetik Wiesbaden
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Hospital Universitari General Vall d'Hebron
    • More information
    • SPAIN
    • Castilla - León
    • VALLADOLID
    • Molecular diagnosis of susceptibility hereditary to breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • IBGM - Instituto de Biología y Genética Molecular
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Hospital Clínico San Carlos
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • CIBIR - Centro de Investigación Biomédica de La Rioja
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (sequencing of BRCA1 and BRCA2 genes)
    • Onkologikoa
    • More information
    • POLAND
    • Warszawa
    • WARSAW
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • MEDGEN
    • More information
    • SPAIN
    • Cataluña
    • TERRASSA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Consorci Sanitari de Terrassa
    • More information
    • SPAIN
    • Andalucía
    • CAMPANILLAS
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes / sequencing, MLPA)
    • GenoClinics
    • More information
    • SPAIN
    • Castilla - León
    • SALAMANCA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes / sequencing; BRIP1, PALB2, RAD51C, BARD1 genes / HA-CSGE, sequencing; CHECK2 gene / dHPLC)
    • Universidad de Salamanca. Facultad de Medicina
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of hereditary breast and ovarian cancer (BRCA1 and 2 genes)
    • Medizinische Universität Wien
    • More information
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular diagnosis of susceptibility to genetic gynecological tumor (BRCA1, BRCA2 genes / PCR, gene sequencing, MLPA, capillary electrophoresis)
    • IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
    • More information
    • SPAIN
    • Cataluña
    • BARCELONA
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes / gene sequencing, MLPA)
    • Hospital del Mar
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of familial breast cancer (BRCA1, BRCA2 genes)
    • Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
    • More information
    • ITALY
    • TOSCANA
    • FIRENZE
    • Molecular diagnosis of breast cancer, familial (BRCA1, BRCA2 and PALB2 genes)
    • Azienda Ospedaliero Universitaria Careggi - NEUROFARBA
    • More information
    • ITALY
    • PUGLIA
    • LECCE
    • Molecular diagnosis of predisposition to breast cancer (HER-2)
    • Presidio Ospedaliero "Vito Fazzi" - ASL LE
    • More information
    • ITALY
    • PUGLIA
    • LECCE
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Presidio Ospedaliero "Vito Fazzi" - ASL LE
    • More information
    • ITALY
    • CAMPANIA
    • AVELLINO
    • Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
    • Azienda Ospedaliera San Giuseppe Moscati
    • More information
    • GERMANY
    • Hessen
    • FRANKFURT AM MAIN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Praxis Dr. med. Ulrike Beudt
    • More information
    • ITALY
    • FRIULI VENEZIA GIULIA
    • AVIANO
    • Molecular diagnosis of familial breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Centro di Riferimento Oncologico
    • More information
    • ITALY
    • LOMBARDIA
    • VARESE
    • Molecular diagnosis with germinal mutation analysis of breast and ovary cancer susceptibility syndrome (BRCA1 and BRCA2 genes)
    • A.O.U. Ospedale di Circolo e Fondazione Macchi - Università dell'Insubria
    • More information
    • SPAIN
    • País Vasco
    • BARAKALDO
    • Molecular diagnosis of predisposition to breast cancer. BRCA1, BRCA2 genes
    • Hospital Universitario Cruces - Osakidetza
    • More information
    • SPAIN
    • Madrid
    • MADRID
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Centro Nacional de Investigaciones Oncológicas (CNIO)
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • RIMINI
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Azienda Ospedaliera "Infermi"
    • More information
    • ITALY
    • SARDEGNA
    • CAGLIARI
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Ospedale "R. Binaghi"
    • More information
    • SPAIN
    • Canarias
    • SANTA CRUZ DE TENERIFE
    • Molecular cytogenetics diagnosis of breast cancer by FISH analysis.
    • Hospital Universitario de Canarias
    • More information
    • SPAIN
    • Galicia
    • A CORUÑA
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • Complejo Hospitalario Universitario A Coruña
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • A.O. S. Andrea
    • More information
    • FINLAND
    • Finland
    • OULU
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, PALB2)
    • Oulu University Hospital
    • More information
    • DENMARK
    • Jylland
    • ALBORG
    • Molecular diagnosis of familial breast cancer (BRCA1, BRCA2)
    • Alborg Sygehus Nord
    • More information
    • CYPRUS
    • Cyprus
    • NICOSIA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1/BRCA2)
    • The Cyprus Institute of Neurology and Genetics
    • More information
    • GREECE
    • ATTIKI
    • ATHENS
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • BIOGENOMICA
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • Hospital San Pedro
    • More information
    • SPAIN
    • Comunidad Valenciana
    • ALICANTE
    • Molecular diagnosis of predisposition to breast cancer (BRCA1/BRCA2)
    • Análisis Genéticos ANCOR S.L.
    • More information
    • GREECE
    • THESSALONIKI
    • THESSALONIKI
    • Molecular diagnosis of predisposition to breast cancer
    • Theagenion Cancer Centre of Thessaloniki
    • More information
    • LEBANON
    • Beyrouth
    • BEIRUT
    • Molecular diagnosis of predisposition to familial breast cancer (complete BRCA1 and BRCA2 gene sequencing)
    • Université Saint-Joseph
    • More information
    • HUNGARY
    • Közép-Magyarország
    • BUDAPEST
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
    • LabOrigo Diagnosztika
    • More information
    • ITALY
    • LIGURIA
    • GENOVA
    • Molecular diagnosis of familial breast cancer
    • Istituto Nazionale per la Ricerca sul Cancro - IST
    • More information
    • ITALY
    • TOSCANA
    • PISA
    • Molecular diagnosis of hereditary breast ovarian cancer (BARD1, BRCA1, BRCA2, BRIP1, PALB2, PTEN genes)
    • Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2 genes)
    • USI - Unione Sanitaria Internazionale
    • More information
    • SPAIN
    • País Vasco
    • SAN SEBASTIÁN
    • Molecular diagnosis of familial breast cancer. BRCA1, BRCA2 genes
    • DNA Data
    • More information
    • CZECH REPUBLIC
    • South Moravia
    • BRNO
    • Molecular diagnosis of predisposition to Breast and Ovarian Cancer (BRCA1, BRCA2)
    • Masaryk Memorial Cancer Institute
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • INCLIVA
    • More information
    • ROMANIA
    • BUCURESTI
    • BUCURESTI
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • GeneticLab
    • More information
    • DENMARK
    • Fyn
    • ODENSE
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 gene analysis by sequencing and MLPA)
    • Amplexa Genetics A/S
    • More information
    • ITALY
    • ABRUZZO
    • CHIETI
    • Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
    • Policlinico Universitario di Chieti
    • More information
    • ITALY
    • LOMBARDIA
    • MONZA
    • Molecular diagnosis of familial breast cancer (BRCA1 and BRCA2 genes)
    • Consorzio per la Genetica Molecolare Umana
    • More information
    • CROATIA
    • CROATIA
    • ZAGREB
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • Rudjer Boskovic Institute
    • More information
    • ISRAEL
    • ISRAEL
    • BEER YAAKOV
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Assaf Harofeh Medical Center
    • More information
    • ISRAEL
    • ISRAEL
    • HAIFA
    • Molecular diagnosis of Breast cancer (BRCA1, BRCA2, Mutation analysis)
    • Carmel Medical Center
    • More information
    • ISRAEL
    • ISRAEL
    • PETAH TIKVA
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Rabin Medical Center - Beilinson Hospital
    • More information
    • ISRAEL
    • ISRAEL
    • HAIFA
    • Molecular diagnosis of Breast Cancer (BRCA1, BRCA2, Mutation analysis)
    • The Bnai Zion Medical Center, Technion-Rappaport Faculty of Medicine
    • More information
    • ISRAEL
    • ISRAEL
    • REHOVOT
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Kaplan Medical Center
    • More information
    • ISRAEL
    • ISRAEL
    • JERUSALEM
    • Molecular diagnosis of Cancer: breast , ovary (BRCA1, BRCA2, Mutation analysis, PGD)
    • Shaare Zedek Medical Center
    • More information
    • ESTONIA
    • Tallinn
    • TALLINN
    • Molecular diagnosis of predisposition to familial breast and ovarian cancer (BRCA1 and BRCA2 mutation analyses)
    • IB Genetics OÜ
    • More information
    • ISRAEL
    • ISRAEL
    • HOLON
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • Wolfson Medical Center
    • More information
    • ISRAEL
    • ISRAEL
    • AFULA
    • Molecular diagnosis of Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2, Mutation analysis)
    • HaEmek Medical Center
    • More information
    • GREECE
    • IRAKLIO
    • HERAKLION
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes: full sequencing and detection of known mutations)
    • DNA analysis
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • MELDOLA
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
    • IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
    • More information
    • SPAIN
    • Cataluña
    • BADALONA
    • Molecular diagnosisi of hereditary breast and ovarian cancer syndrome (PALB2 gene)
    • IMPPC - Instituto de Medicina Predictiva y Personalizada del Cáncer
    • More information
    • SPAIN
    • Madrid
    • SAN SEBASTIÁN DE LOS REYES
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (entire coding sequence of BRCA1, BRCA2 and PALB2 genes, and exon 11 in BRCA1 and BRCA2; BRCA1 gene / mutations in exons 2, 3, 5, 8, 11, 18, 20 and 23; BRCA2 gene / mutations in exons 2, 10, 11 and 23 - MLPA in BRCA1 and BRCA2 genes)
    • Laboratorio de Genética Clínica, S.L.
    • More information
    • SPAIN
    • Andalucía
    • ARMILLA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (entire coding sequence of BRCA1 gene / exons 2, 3, 5, 8, 11, 13, 18, 20 and 23; BRCA2 gene / exons 2, 10, 11 and 23)
    • Lorgen G.P.
    • More information
    • POLAND
    • Bydgoszcz
    • BYDGOSZCZ
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and CHEK2 genes)
    • More information
    • FRANCE
    • BOURGOGNE
    • DIJON
    • Molecular diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes)
    • CLCC Georges-François Leclerc
    • More information
    • SPAIN
    • Madrid
    • MAJADAHONDA
    • Molecular diagnosis of hereditary breast and ovarian cancer syndrome (sequencing of BRCA1 and BRCA2 genes)
    • Genyca Innova
    • More information
    • GERMANY
    • Berlin
    • BERLIN
    • Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 gene: seq/MLPA; BRCA2, BRIP1, CDH1, CHEK2, NBN, RAD50, RAD51C, PALB2, PTEN genes: sequencing)
    • ATG GenMed GmbH
    • More information
    • ITALY
    • VENETO
    • CHIOGGIA
    • Molecular diagnosis of predisposition to familial breast cancer (BRCA1 and BRCA2 genes)
    • Laboratori Clodia Sas
    • More information
    • AUSTRALIA
    • Queensland
    • BRISBANE
    • Molecular diagnosis of susceptibility to hereditary breast and ovarian cancer syndrome (BRCA1 and BRCA2 genes: sequencing and MLPA)
    • G4L - Genomics For Life
    • More information